文献速递腹部CT

胆管导管内乳头状肿瘤与乳头状胆管癌的CT影像比较

CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.
PubMed 文献 · Eur Radiol · 2018-12-05

本研究基于537例连续切除的胆道肿瘤,按新提出的组织学诊断标准识别出19例胆管导管内乳头状肿瘤(IPNB)和48例乳头状胆管癌(PCC),比较两组临床与影像特征。结果显示肿瘤位置和囊性表现是强鉴别因素,联合应用可对78%的乳头状胆管肿瘤进行分类;IPNB多位于肝内胆管(79%),PCC多位于远端胆管(85%)。

要点

  • 肝内位置和受累胆管囊性扩张是IPNB与PCC的强鉴别因素。
  • 联合肿瘤位置和囊性表现可对78%的乳头状胆管肿瘤进行分类。
  • 壁结节形态及邻近胆管异常强化有助于鉴别IPNB与PCC。

核心结论

  • 肿瘤位置、肿瘤形态、壁结节表现、未受累胆管扩张及邻近胆管异常强化等影像表现似乎有助于鉴别IPNB与PCC。

研究设计与样本

  • 经机构审查委员会批准,采用新提出的胆道乳头状肿瘤组织学诊断标准,从12.5年间连续切除的537例胆道肿瘤中选取IPNB和PCC,比较两组临床与影像特征。

关键影像表现/征象

  • 囊性表现高度提示IPNB(p < 0.001)。
  • IPNB中15/19例(79%)位于肝内胆管,PCC中41/48例(85%)位于远端胆管。
  • 支持IPNB的其他影像表现包括叶状壁结节、下游胆管扩张及邻近胆管无异常强化。
  • 2例非浸润性或微浸润IPNB在>3年前的腹部影像回顾中可见小结节或囊性病变,提示IPNB进展性可能低于目前认识。

诊断标准与关键数值

  • 联合肿瘤位置和囊性表现,78%的乳头状胆管肿瘤可分类为IPNB或PCC。
  • IPNB在胆道肿瘤中的估计患病率为4%。

临床应用与阅片要点

  • 阅片时注意肿瘤位置(肝内 vs 远端胆管)及受累胆管是否呈囊性扩张,两者联合有助于鉴别IPNB与PCC。
  • 观察壁结节形态(叶状)及邻近胆管有无异常强化,辅助鉴别诊断。
  • 约一半IPNB为因其他目的行影像检查时偶然发现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify imaging features that assist in discriminating intraductal papillary neoplasms of the bile duct (IPNBs) from papillary cholangiocarcinomas (PCCs).

METHODS: This study was approved by the institutional review board. Using the recently proposed histological diagnostic criteria for biliary papillary neoplasms, IPNBs and PCCs were selected from 537 biliary neoplasms consecutively resected in a 12.5-year period. Clinical and imaging features were compared between the two groups.

RESULTS: The histology review identified 19 IPNBs and 48 PCCs, representing an estimated prevalence of IPNBs among biliary neoplasms of 4%. Approximately one half of IPNBs were incidentally found on imaging conducted for other purposes. In terms of tumor location, 15/19 IPNBs (79%) developed in intrahepatic bile ducts, and 41/48 PCCs (85%) in the distal bile duct. Cystic appearance was highly suggestive for IPNBs (p < 0.001). Using these two parameters, 78% of papillary bile duct neoplasms could be classified into IPNBs or PCCs. Other imaging findings favoring IPNBs included frond-like mural nodule, downstream bile duct dilatation, and the lack of abnormal enhancement in the adjacent bile duct. Interestingly, two patients with non-invasive or microinvasive IPNB had undergone abdominal imaging studies > 3 years before, and a retrospective review of the previous images identified small nodular or cystic lesions, suggesting a less progressive nature of IPNBs than currently thought.

CONCLUSIONS: Imaging findings useful for discriminating IPNBs from PCCs appear to be tumor location, shape of tumor, appearance of mural nodules, duct dilatation at unaffected duct, and abnormal enhancement of the adjacent bile duct.

KEY POINTS: • Intrahepatic location and cystic dilatation of the affected bile duct are the strong discriminators between IPNBs and PCCs. • The shape of the mural nodule and appearance of the neighboring bile duct are helpful for distinguishing IPNBs and PCCs. • The less aggressive behavior of IPNBs compared with PCCs may facilitate less invasive management in patients with IPNB.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Komori T, Inoue D, Zen Y, et al. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas. Eur Radiol. 2018. PMID: 30519930. doi:10.1007/s00330-018-5841-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。